← Leaderboards
Mahmoud H El Kouni
University Of Alabama At Birmingham
$2,872,396
Attributed
$2,872,396
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $498.7K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$2,872,396 · 4
By mechanism
R01$2,695,544 · 3
R41$176,852 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Richard J. Whitley$15,110,969
- Robert B. Diasio$27,640,960
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationLaboratory MouseToxoplasma GondiiAdenosine KinaseEnzyme ActivityToxoplasmosisEnzyme InhibitorsPurine AnalogChemical SynthesisDrug Design /Synthesis /ProductionPharmacokineticsX Ray CrystallographyTissue /Cell CultureRecombinant ProteinsMolecular CloningNonhuman Therapy EvaluationMicroorganism GeneticsParasitic Disease ChemotherapyInosineMicroorganism CultureAntiprotozoal AgentsCellsCell LineAnalog
Grant awards (8)
Toxoplasma Adenosine Kinase & Chemotherapy$498,669
R01 · FY2007 · AI · contact PI
Toxoplasma Adenosine Kinase & Chemotherapy$498,605
R01 · FY2006 · AI · contact PI
Toxoplasma Adenosine Kinase &Chemotherapy$495,731
R01 · FY2005 · AI
Toxoplasma Adenosine Kinase &Chemotherapy$503,793
R01 · FY2004 · AI
Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy$176,852
R41 · FY2002 · CA
ADENOSINE KINASE TARGET FOR CHEMOTHERAPY IN TGONDII$240,815
R01 · FY2001 · AI
ADENOSINE KINASE TARGET FOR CHEMOTHERAPY IN TGONDII$233,799
R01 · FY2000 · AI
MECHANISMS OF NUCLEOSIDES INDUCED TOXICITY AND ACTIVITY$224,132
R01 · FY2000 · AI